Skip to main content
logo
Zhejiang CONBA Pharmaceutical Co.,Ltd. (SHA:600572)
China flag China · Delayed Price · Currency is CNY
4.320
-0.060 (-1.37%)
Sep 10, 2026, 3:00 PM CST

SHA:600572 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
498.53474.36622.42591.57358.122,017
Depreciation & Amortization
334.43336.49344.94324.35277.48286.68
Other Amortization
23.1418.319.058.779.3817.41
Loss (Gain) From Sale of Assets
0.93-4.89-16.91-35.68-36.51-43.18
Asset Writedown & Restructuring Costs
26.626.811.827.182.3396.67
Loss (Gain) From Sale of Investments
3.95-105.25-96.8761.31202.15-1,881
Provision & Write-off of Bad Debts
2.861.011.041.070.2436.57
Other Operating Activities
71.5853.299.85155.42163.86269.06
Change in Accounts Receivable
-168.54156.52138-271.4447.95-360.47
Change in Inventory
34.417.2219.2-244.97-111.02-158.76
Change in Accounts Payable
354.33-40.85-145.41358.69246.19341.51
Change in Other Net Operating Assets
-7210.982426.364.7930.52
Operating Cash Flow
1,083942.611,013898.641,155891.23
Operating Cash Flow Growth
-2.21%-6.91%12.67%-22.23%29.65%-28.68%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-113.7-147.26-290.63-209.14-291.75-581.42
Sale of Property, Plant & Equipment
12.6825.5323.8396.34164.0121.02
Cash Acquisitions
---8.79-206.31-
Divestitures
-----0.011,479
Investment in Securities
-383.8922.6222.74-207.1394.24168.48
Other Investing Activities
10.4834.5732.5622.0928.720.31
Investing Cash Flow
-474.43-64.54-211.5-289.05-211.111,087

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-282.03750.271,7551,7601,912
Total Debt Issued
173.25282.03750.271,7551,7601,912
Long-Term Debt Repaid
--409.27-1,565-1,716-2,060-2,791
Lease Payments
------4.87
Net Debt Issued (Repaid)
-197.3-127.25-815.1138.44-300.45-879.27
Issuance of Common Stock
62.4455.5248.7-1.5-
Repurchase of Common Stock
---299.99---
Common Dividends Paid
-384.19-383.64-523.54-420.13-490.35-85.01
Other Financing Activities
-20.58-38.09-324.96-337.4-135.41-61.74
Financing Cash Flow
-539.64-493.45-1,915-719.08-924.71-1,026

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-4.99-1.555.112.999.110.05
Net Cash Flow
64.04383.06-1,109-106.5128.77952.21

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
969.4795.35721.9689.5863.73309.8
Free Cash Flow Growth
12.39%10.17%4.70%-20.17%178.80%-60.75%
Free Cash Flow Margin
14.22%12.29%11.08%10.24%14.39%4.72%
Free Cash Flow Per Share
0.390.320.290.270.340.12
Levered Free Cash Flow
454.32720.52516.7664.78602.51-18.09
Unlevered Free Cash Flow
457.89725.39529.7687.53633.4327.67
Free Cash Flow After Leases
969.4795.35721.9689.5863.73304.94

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
689.38646.27518.05722.62562.67619.14
Change in Working Capital
121.08142.5547.18-215.36178.4391.26